Mediolanum International Funds Ltd Sells 17,819 Shares of Avantor, Inc. (NYSE:AVTR)

Mediolanum International Funds Ltd reduced its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 2.4% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 721,736 shares of the company’s stock after selling 17,819 shares during the period. Mediolanum International Funds Ltd’s holdings in Avantor were worth $18,612,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Graypoint LLC lifted its position in shares of Avantor by 3.8% during the 1st quarter. Graypoint LLC now owns 11,414 shares of the company’s stock worth $292,000 after buying an additional 423 shares during the last quarter. Intech Investment Management LLC increased its holdings in Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after purchasing an additional 514 shares in the last quarter. Arizona State Retirement System increased its holdings in Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after purchasing an additional 528 shares in the last quarter. Veracity Capital LLC increased its holdings in Avantor by 1.0% in the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after purchasing an additional 543 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in Avantor by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after purchasing an additional 733 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AVTR. Evercore ISI lowered their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Robert W. Baird increased their price target on Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Barclays increased their price target on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. TD Cowen increased their price target on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Finally, UBS Group decreased their price target on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Avantor presently has an average rating of “Moderate Buy” and an average price target of $28.00.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.50% of the company’s stock.

Avantor Stock Down 3.4 %

NYSE:AVTR traded down $0.79 on Friday, hitting $22.48. The stock had a trading volume of 2,745,512 shares, compared to its average volume of 6,413,937. Avantor, Inc. has a 52 week low of $16.63 and a 52 week high of $28.00. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. The business’s fifty day moving average is $25.59 and its 200 day moving average is $24.30. The company has a market cap of $15.27 billion, a PE ratio of 59.69, a P/E/G ratio of 2.93 and a beta of 1.33.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. On average, equities research analysts expect that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.